| US4780409A
              (en)
            
            * | 1985-05-02 | 1988-10-25 | Genetic Systems Corporation | Thermally induced phase separation immunoassay | 
        
          | US4766106A
              (en)
            
            * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation | 
        
          | US5206344A
              (en)
            
            * | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof | 
        
          | US4959305A
              (en)
            
            * | 1986-06-18 | 1990-09-25 | Miles Inc. | Reversible immobilization of assay reagents in a multizone test device | 
        
          | ES2058121T3
              (es)
            
            * | 1986-09-17 | 1994-11-01 | Beecham Group Plc | Preparacion enzimatica inmovilizada y su uso. | 
        
          | US4894226A
              (en)
            
            * | 1986-11-14 | 1990-01-16 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polyproline conjugation | 
        
          | US4847325A
              (en)
            
            * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 | 
        
          | US5510418A
              (en)
            
            * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates | 
        
          | US5162430A
              (en)
            
            * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates | 
        
          | US5306500A
              (en)
            
            * | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates | 
        
          | US5565519A
              (en)
            
            * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications | 
        
          | US5166322A
              (en)
            
            * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof | 
        
          | AU4104093A
              (en)
            
            * | 1992-04-20 | 1993-11-18 | Rufeld, Inc. | Method and compositions for treatment of pyonecrotic processes | 
        
          | US5545553A
              (en)
            
            * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them | 
        
          | US7883693B2
              (en)
            
            * | 1995-12-18 | 2011-02-08 | Angiodevice International Gmbh | Compositions and systems for forming crosslinked biomaterials and methods of preparation of use | 
        
          | DK0876165T3
              (da) | 1995-12-18 | 2007-08-06 | Angiotech Biomaterials Corp | Tværbundne polymersammensætninger og fremgangsmåder til deres fremstilling | 
        
          | US6833408B2
              (en)
            
            * | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials | 
        
          | US6458889B1
              (en) | 1995-12-18 | 2002-10-01 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use | 
        
          | JPH11502255A
              (ja)
            
            * | 1995-12-29 | 1999-02-23 | ザ、プロクター、エンド、ギャンブル、カンパニー | 固定化酵素を含有する洗剤組成物 | 
        
          | WO1998021302A1
              (en)
            
            * | 1996-11-14 | 1998-05-22 | Polymer Technology Corporation | Use of water soluble enzyme-polymer conjugates for cleaning contact lenses | 
        
          | LT2599503T
              (lt)
            
            * | 1998-10-16 | 2017-06-26 | Biogen Ma Inc. | Interferono beta-1a polimero konjugatai ir jų panaudojimas | 
        
          | US7179617B2
              (en) | 2001-10-10 | 2007-02-20 | Neose Technologies, Inc. | Factor IX: remolding and glycoconjugation of Factor IX | 
        
          | US7226903B2
              (en)
            
            * | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta | 
        
          | US7173003B2
              (en)
            
            * | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF | 
        
          | US7399613B2
              (en)
            
            * | 2001-10-10 | 2008-07-15 | Neose Technologies, Inc. | Sialic acid nucleotide sugars | 
        
          | US7795210B2
              (en)
            
            * | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods | 
        
          | US7265085B2
              (en)
            
            * | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycoconjugation methods and proteins/peptides produced by the methods | 
        
          | US8008252B2
              (en)
            
            * | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII | 
        
          | US7265084B2
              (en)
            
            * | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods | 
        
          | US7439043B2
              (en)
            
            * | 2001-10-10 | 2008-10-21 | Neose Technologies, Inc. | Galactosyl nucleotide sugars | 
        
          | US7157277B2
              (en)
            
            * | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII | 
        
          | US7214660B2
              (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin | 
        
          | US7125843B2
              (en)
            
            * | 2001-10-19 | 2006-10-24 | Neose Technologies, Inc. | Glycoconjugates including more than one peptide | 
        
          | EP2292271A3
              (en) | 2001-10-10 | 2011-09-14 | BioGeneriX AG | Remodelling and glycoconjugation of an antibody | 
        
          | US7696163B2
              (en) | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin | 
        
          | US7297511B2
              (en)
            
            * | 2001-10-10 | 2007-11-20 | Neose Technologies, Inc. | Interferon alpha: remodeling and glycoconjugation of interferon alpha | 
        
          | US7473680B2
              (en)
            
            * | 2001-11-28 | 2009-01-06 | Neose Technologies, Inc. | Remodeling and glycoconjugation of peptides | 
        
          | DE60336555D1
              (de)
            
            * | 2002-06-21 | 2011-05-12 | Novo Nordisk Healthcare Ag | Pegylierte glykoformen von faktor vii | 
        
          | US8129330B2
              (en)
            
            * | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | 
        
          | DE60331367D1
              (de)
            
            * | 2002-12-30 | 2010-04-01 | Angiotech Int Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung | 
        
          | WO2004060405A2
              (en)
            
            * | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Tissue reactive compounds and compositions and uses thereof | 
        
          | ES2420581T3
              (es)
            
            * | 2003-03-14 | 2013-08-26 | Biogenerix Gmbh | Polímeros solubles en agua ramificados y sus conjugados | 
        
          | US7691603B2
              (en)
            
            * | 2003-04-09 | 2010-04-06 | Novo Nordisk A/S | Intracellular formation of peptide conjugates | 
        
          | EP2338333B1
              (en) | 2003-04-09 | 2017-09-06 | ratiopharm GmbH | Glycopegylation methods and proteins/peptides produced by the methods | 
        
          | US8791070B2
              (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX | 
        
          | CA2524936A1
              (en) | 2003-05-09 | 2004-12-02 | Neose Technologies, Inc. | Compositions and methods for the preparation of human growth hormone glycosylation mutants | 
        
          | US9005625B2
              (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates | 
        
          | US20080305992A1
              (en)
            
            * | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin | 
        
          | MXPA06005732A
              (es)
            
            * | 2003-11-24 | 2006-08-17 | Neose Technologies Inc | Eritropoyetina glucopegilada. | 
        
          | US8633157B2
              (en)
            
            * | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin | 
        
          | US20060040856A1
              (en)
            
            * | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX | 
        
          | US7956032B2
              (en)
            
            * | 2003-12-03 | 2011-06-07 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor | 
        
          | ES2422187T3
              (es)
            
            * | 2003-12-03 | 2013-09-09 | Biogenerix Ag | Factor estimulante de colonias de granulocitos glicopegilados | 
        
          | US20080318850A1
              (en)
            
            * | 2003-12-03 | 2008-12-25 | Neose Technologies, Inc. | Glycopegylated Factor Ix | 
        
          | ES2560657T3
              (es)
            
            * | 2004-01-08 | 2016-02-22 | Ratiopharm Gmbh | Glicosilación con unión en O de péptidos G-CSF | 
        
          | JP4124361B2
              (ja)
            
            * | 2004-02-16 | 2008-07-23 | 農工大ティー・エル・オー株式会社 | 化学物質の分離方法 | 
        
          | BRPI0510477B1
              (pt) | 2004-04-28 | 2023-01-17 | Angiotech Biomaterials Corporation | Método para formar um gel e dispositivo para uso em aplicações médicas | 
        
          | KR20070008645A
              (ko)
            
            * | 2004-05-04 | 2007-01-17 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | 폴리펩티드의 o-연결된 단백당형 및 그들의 제조 방법 | 
        
          | WO2006010143A2
              (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] | 
        
          | WO2006031811A2
              (en)
            
            * | 2004-09-10 | 2006-03-23 | Neose Technologies, Inc. | Glycopegylated interferon alpha | 
        
          | US8303973B2
              (en) | 2004-09-17 | 2012-11-06 | Angiotech Pharmaceuticals (Us), Inc. | Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use | 
        
          | JP2008514215A
              (ja)
            
            * | 2004-09-29 | 2008-05-08 | ノボ  ノルディスク  ヘルス  ケア  アクチェンゲゼルシャフト | 改変タンパク質 | 
        
          | EP3061461A1
              (en)
            
            * | 2004-10-29 | 2016-08-31 | ratiopharm GmbH | Remodeling and glycopegylation of fibroblast growth factor (fgf) | 
        
          | WO2006074279A1
              (en)
            
            * | 2005-01-06 | 2006-07-13 | Neose Technologies, Inc. | Glycoconjugation using saccharyl fragments | 
        
          | MX2007008229A
              (es) | 2005-01-10 | 2007-09-11 | Neose Technologies Inc | Factor estimulador de colonias de granulocitos glicopegilado. | 
        
          | WO2006105426A2
              (en)
            
            * | 2005-03-30 | 2006-10-05 | Neose Technologies, Inc. | Manufacturing process for the production of peptides grown in insect cell lines | 
        
          | US9187546B2
              (en)
            
            * | 2005-04-08 | 2015-11-17 | Novo Nordisk A/S | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants | 
        
          | US20080255026A1
              (en) | 2005-05-25 | 2008-10-16 | Glycopegylated Factor 1X | Glycopegylated Factor Ix | 
        
          | WO2006127910A2
              (en)
            
            * | 2005-05-25 | 2006-11-30 | Neose Technologies, Inc. | Glycopegylated erythropoietin formulations | 
        
          | US20070105755A1
              (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides | 
        
          | US20090305967A1
              (en)
            
            * | 2005-08-19 | 2009-12-10 | Novo Nordisk A/S | Glycopegylated factor vii and factor viia | 
        
          | US20090048440A1
              (en)
            
            * | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes | 
        
          | WO2008011633A2
              (en) | 2006-07-21 | 2008-01-24 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences | 
        
          | EP2054521A4
              (en)
            
            * | 2006-10-03 | 2012-12-19 | Novo Nordisk As | PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES | 
        
          | WO2008060780A2
              (en)
            
            * | 2006-10-04 | 2008-05-22 | Novo Nordisk A/S | Glycerol linked pegylated sugars and glycopeptides | 
        
          | US20080207487A1
              (en)
            
            * | 2006-11-02 | 2008-08-28 | Neose Technologies, Inc. | Manufacturing process for the production of polypeptides expressed in insect cell-lines | 
        
          | PL2144923T3
              (pl) | 2007-04-03 | 2013-12-31 | Biogenerix Ag | Sposoby leczenia z użyciem glikopegilowanego G-CSF | 
        
          | US20090053167A1
              (en)
            
            * | 2007-05-14 | 2009-02-26 | Neose Technologies, Inc. | C-, S- and N-glycosylation of peptides | 
        
          | US20110177029A1
              (en)
            
            * | 2007-06-04 | 2011-07-21 | Novo Nordisk A/S | O-linked glycosylation using n-acetylglucosaminyl transferases | 
        
          | CN101778859B
              (zh)
            
            * | 2007-06-12 | 2014-03-26 | 诺和诺德公司 | 改良的用于生产核苷酸糖的方法 | 
        
          | NZ583276A
              (en) | 2007-08-27 | 2012-06-29 | Biogenerix Ag | Liquid formulations of granulocyte colony stimulating factor and polymer conjugates | 
        
          | US8207112B2
              (en)
            
            * | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate | 
        
          | DK3078743T3
              (da) | 2007-09-28 | 2020-08-10 | Portola Pharm Inc | Antidoter til faktor xa-inhibitorer og fremgangsmåder til anvendelse af disse | 
        
          | CN104689298A
              (zh) | 2008-01-22 | 2015-06-10 | 阿拉伊姆药品公司 | 用于预防和治疗组织损伤相关疾病和病症的组织保护肽和肽类似物 | 
        
          | CA2715465C
              (en) | 2008-02-27 | 2017-03-21 | Novo Nordisk A/S | Conjugated factor viii molecules | 
        
          | EP2672259A1
              (en) | 2008-05-13 | 2013-12-11 | Advanced Liquid Logic, Inc. | Droplet actuator devices, systems and methods | 
        
          | EP2838566A2
              (en) | 2012-04-16 | 2015-02-25 | Cantab Biopharmaceuticals Patents Limited | Optimised subcutaneous therapeutic agents | 
        
          | EP3448415A4
              (en) | 2016-04-29 | 2019-11-06 | Araim Pharmaceuticals, Inc. | TREATMENT-PROOFING PEPTIDES FOR THE PREVENTION AND TREATMENT OF DISEASES AND DISORDERS RELATED TO TISSUE DAMAGE |